Crossref
0270 Therapeutic drug monitoring of infliximab in hidradenitis suppurativa
Journal of Investigative Dermatology · 2026-08 · 146 (8) · S47
DOI: 10.1016/j.jid.2026.06.301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von A. Young und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Young, A., Zhan, X., Pino, J. L., Scott, K., Djemil, R., Bradford, L., Raut, R., & Mi, Q. (2026). 0270 Therapeutic drug monitoring of infliximab in hidradenitis suppurativa. Journal of Investigative Dermatology, 146(8), S47. https://doi.org/10.1016/j.jid.2026.06.301
Vancouver
Young A, Zhan X, Pino JL, Scott K, Djemil R, Bradford L, et al. 0270 Therapeutic drug monitoring of infliximab in hidradenitis suppurativa. Journal of Investigative Dermatology. 2026;146(8):S47. doi:10.1016/j.jid.2026.06.301
BibTeX
@article{Young2026,
author = {Young, A. and Zhan, X. and Pino, J. Labrador and Scott, K. and Djemil, R. and Bradford, L. and Raut, R. and Mi, Q.},
title = {0270 Therapeutic drug monitoring of infliximab in hidradenitis suppurativa},
journal = {Journal of Investigative Dermatology},
year = {2026},
volume = {146},
number = {8},
pages = {S47},
doi = {10.1016/j.jid.2026.06.301}
}
EUVIMED